Celgene Pharmaceuticals has developed a new program called Fast Track for First Prescription™ to help eligible patients receive their first prescriptions for a Celgene product as quickly and efficiently as possible.
Fast Track is an optional service of Celgene Patient Support that facilitates communication between doctors, patients, insurance providers, risk management programs, pharmacies, and co-pay foundations. A Celgene Patient Support coordinator will ensure that “all the ducks are in a row” as quickly as possible, and remove the hurdles to accessing that first cycle of medication.
To be eligible, patients must be receiving their first prescription of either Thalomid or Revlimid, must have documented proof of insurance, and must be registered in a Celgene risk management program and have a valid authorization number.
For more information on the program, call the IMF Hotline at 800-452-2873.